EC to keep eye on settlements, patent defence after pharma probe
The European Commission’s enquiry into the pharmaceuticals sector is set to result in a range of regulatory measures to ease the path for drugs coming to market, but possible competition enforcement...To view the full article, register now.
Already a subscriber? Click here to view full article